ABEO R&D Expense Growth
Abeona Therapeutics Inc · R&D Expense Growth
ABEO R&D Expense Growth
Latest reported-21.97%period ending
ABEO FY R&D Growth (YoY) (0.00% → -21.97%)
Latest values, visible window
High-resolution chart · PNG
ABEO r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -21.9674% | |
| 10.5143% | |
| 7.3399% | |
| -25.2053% | |
| 28.4913% | |
| -43.9441% | |
| 38.9374% | |
| 127.7827% | |
| 59.4463% | |
| 125.9809% | |
| 1,315.9159% | |
| -62.3303% | |
| -56.0199% | |
| -43.8391% | |
| 6.8677% | |
| 26.0444% | |
| -78.9344% | |
| 384.7425% | |
| 26.7414% | |
| -26.2307% | |
| 19.1863% | |
| -8.3954% | |
| -63.7101% | |
| 68.2798% | |
| 4.1677% | |
| 149.1915% | |
| -10.6667% | |
| -26.0173% | |
| 73.1673% | |
| 12.1309% | |
| 0% |